Search Results 511-520 of 21094 for Secondary

  1. Oncology (Medical) - Clinical trials

    This may lead to an increased risk of serious infections requiring hospitalization and an increased risk of secondary non-blood-based (hematologic) cancers.

  2. Mouth sores caused by cancer treatment: How to cope - Mayo Clinic

    MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2022; doi:10.1002/cncr.33100. Print. Related ...

  3. Breast cancer - Doctors and departments - Mayo Clinic

    ... Secondary hyperparathyroidism, Parathyroid disease, Tertiary hyperparathyroidism, Multinodular goiter, Insulinoma, Aldosteronoma, BRCA gene mutation, MEN 2B.

  4. Breast cancer - Doctors and departments - Mayo Clinic

    ... Secondary hyperparathyroidism, Parathyroid disease, Tertiary hyperparathyroidism, Multinodular goiter, Insulinoma, Aldosteronoma, BRCA gene mutation, MEN 2B.

  5. Breast cancer - Doctors and departments - Mayo Clinic

    ... Secondary hyperparathyroidism, Parathyroid disease, Tertiary hyperparathyroidism, Multinodular goiter, Insulinoma, Aldosteronoma, BRCA gene mutation, MEN 2B.

  6. Breast cancer - Doctors and departments - Mayo Clinic

    ... Secondary hyperparathyroidism, Parathyroid disease, Tertiary hyperparathyroidism, Multinodular goiter, Insulinoma, Aldosteronoma, BRCA gene mutation, MEN 2B.

  7. Breast cancer - Doctors and departments - Mayo Clinic

    ... Secondary hyperparathyroidism, Parathyroid disease, Tertiary hyperparathyroidism, Multinodular goiter, Insulinoma, Aldosteronoma, BRCA gene mutation, MEN 2B.

  8. Breast cancer - Doctors and departments - Mayo Clinic

    ... Secondary hyperparathyroidism, Parathyroid disease, Tertiary hyperparathyroidism, Multinodular goiter, Insulinoma, Aldosteronoma, BRCA gene mutation, MEN 2B.

  9. Breast cancer - Doctors and departments - Mayo Clinic

    ... Secondary hyperparathyroidism, Parathyroid disease, Tertiary hyperparathyroidism, Multinodular goiter, Insulinoma, Aldosteronoma, BRCA gene mutation, MEN 2B.

  10. Clinical trials - Oncology (Medical)

    This may lead to an increased risk of serious infections requiring hospitalization and an increased risk of secondary non-blood-based (hematologic) cancers.